Drug Trial Radar · NCT06551246
Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry)
Last checked: Nov 20, 2026Latest source record: Jun 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
236
Planned (sponsor's estimate)
Start
Jun 27, 2024
Primary completion
Oct 1, 2027
Study completion Dec 1, 2027
Sponsor
- Lead sponsor
- University of AarhusAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 13, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 5 years, up to 14 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective is to evaluate if (1) combination therapy of solifenacin and mirabegron in low doses is superior to monotherapy of solifenacin in high dose and if (2) combination therapy of mirabegron and solifenacin in low doses is superior to monotherapy of mirabegron in high dose in treatment of daytime urinary incontinence among children aged 5 to 14 years who are none complete responders to respectively monotherapy of solifenacin in low dose or monotherapy of mirabegron in low dose. In total, 236 children diagnosed with daytime urinary incontinence will be randomized 1:1:1:1 to one of four treatment groups. Total pharmacological treatment period will be 18 weeks.
Conditions
- Urinary Incontinence in Children
Interventions
SolifenacinDrug
According to randomization.
MirabegronDrug
According to randomization.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment responseTime frame: From study week 6 and through study completion, an average of 18 weeks in total
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Department of Pediatric and Adolescent Medicine, Aalborg University Hospital
Aalborg, Aalborg, Denmark · Recruiting
Department of Pediatric and Adolescent Medicine, Aarhus University Hospital
Aarhus, Aarhus N, Denmark · Recruiting
Department of Pediatric and Adolescent medicine, Esbjerg Hospital
Esbjerg, Esbjerg, Denmark · Recruiting
Department of Pediatric and Adolescent Medicine, Gødstrup Hospital
Herning, Herning, Denmark · Recruiting
Department of Pediatric and Adolescent Medicine, Kolding Hospital
Kolding, Kolding, Denmark · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.